Search
English | Español
Bernheim Kelley Personal Injury Lawyers
Call
Menu

FreeStyle Libre 3 & 3 Plus Sensors Linked to Incorrect Low Readings, Serious Injuries & Deaths

Bernheim Kelley Investigating Claims for Diabetics Harmed by Recalled CGM Sensors & Taking New Clients Nationwide

FORT LAUDERDALE, FL – February 5, 2026 – Bernheim Kelley Injury Lawyers is already representing individuals and families impacted by the FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensor recall and continues to review and accept additional cases nationwide. The FDA has classified the issue as a Class I recall, its most serious recall category, after Abbott identified a manufacturing issue that can cause falsely low glucose readings in certain sensors. The FDA warns that those inaccurate readings may lead to incorrect treatment decisions and serious harm, including DKA, hospitalization, or death.

The Libre 3 and Libre 3 Plus are continuous glucose monitoring systems (CGMs). They are applied to the back of the arm and automatically send glucose readings to a smartphone. People with diabetes who use these sensors can check their glucose levels at any time and adjust accordingly.

Abbott markets the devices as “accurate and reliable,” yet they initiated an urgent medical device correction in November 2025 after internal testing found that some sensors may provide incorrect low glucose readings. The FDA later classified the action as a Class I recall.

When a sensor underreports blood sugar, a person may treat a false low or delay insulin when insulin is needed. For people living with diabetes, the margin of error is small, and the fallout can be severe, potentially leading to emergency care, hospitalization, diabetic ketoacidosis (DKA), and in the most devastating cases, death.

As of January 7, 2026, Abbott reported 860 serious injuries and 7 deaths worldwide associated with the recalled sensors. They stated that the manufacturing issue was tied to one production line and that the action involved approximately 3 million sensors in the United States. The company estimated that about half were already used or expired, leaving potentially 1.5 million still out there.

Why This Matters for People Living with Diabetes

CGM readings influence what a person with diabetes does next. If a sensor shows a falsely low reading, a person may take glucose, eat extra carbs, or hold back insulin. For someone who needs insulin, delaying or reducing insulin can allow blood sugar to climb and stay high.

One of the most serious risks is diabetic ketoacidosis (DKA). DKA can happen when the body does not have enough insulin and starts producing ketones. It can come on quickly and often requires emergency treatment and hospitalization.

“This is a trust issue,” said Jesse Bernheim, CEO and Trial Attorney at Bernheim Kelley. “People living with diabetes rely on these sensors to help them make real-time decisions about their health. If a device is giving false low readings, it can put people in real danger. Families deserve answers and accountability when a product meant to support their health, instead, endangers it.”

What Libre 3 & Libre 3 Plus Users Should Do Now

The FDA and Abbott recommend steps to help users identify affected products and protect themselves:

If you or a loved one went to the ER, was hospitalized, was treated for DKA, or passed away after using a recalled sensor, you may have legal options.

Bernheim Kelley is currently working with families impacted by these recalled sensors and continuing to evaluate new claims nationwide. The firm offers free case evaluations to help individuals and families understand their options and determine whether they may have a viable claim for compensation.

“We want people to know they are not alone,” Bernheim added. “If something felt off, if a loved one ended up in the hospital, or if you are grieving a loss, it’s worth asking the question: could a recalled sensor have played a role? We will listen, tell you what we know, and help you take the next step.”

If you believe you or someone you love was harmed after using a recalled FreeStyle Libre 3 or Libre 3 Plus sensor, contact Bernheim Kelley today for a free case evaluation.

About Bernheim Kelley Injury Lawyers

Bernheim Kelley is a nationally recognized law firm with decades of experience representing clients in mass tort, product liability, and personal injury cases. Founded by Jesse Bernheim, Esq., the firm has secured over $1 billion in settlements and judgments on behalf of clients nationwide, including $200 million verdict against R.J. Reynolds Tobacco Company and a $250+ million GranuFlo settlement.

Earning recognition for delivering excellent, individualized legal representation, Bernheim Kelley is dedicated to protecting the legal rights of those who have suffered harm due to negligence. They believe that Real Justice goes beyond compensation to restore dignity, peace of mind, and confidence in the future for people and families whose lives have been upended.

Facebook
Instagram
X
LinkedIn
YouTube

###

Call for your
Free Consultation!